Usefulness of enhanced insulin secretion during an oral glucose tolerance test as a predictor of restenosis after direct percutaneous transluminal coronary angioplasty during acute myocardial infarction in patients without diabetes mellitus

American Journal of Cardiology

Volumn 81, Issue 6, 1998, Pages 698-701

  Osanai, Hiroyuki ^a   Kanayama, Hitoshi ^b   Miyazaki, Yutaka ^b   Fukushima, Akihiko ^b   Shinoda, Masanori ^b   Ito, Takayuki ^b  

^a Kamo Hospital   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTERY DIAMETER; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; FEMALE; HUMAN; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PRIORITY JOURNAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RECURRENCE; REGRESSION ANALYSIS;

EID: 0032521534     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)01021-7     Document Type: Article

References (13)

1. Bourassa MG, Lesperance J, Eastwood C, Schwartz L, Cote G, Kazim F, Hudon G. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1991;18:368-376.
2. Hearn JA, Donohue BC, Ba'albaki H, Douglas JS, King SB, Lembo NJ, Roubin GS, Sgoutas DS. Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1992;69:736-739.
3. Shah PK, Amin J. Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty. Circulation 1992;85:1279-1285.
4. Pyörälä K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki policemen study population. Acta Med Scand (suppl) 1985;701:38-52.
5. Ducimetiere P, Eschwege E, Papoz L, Richard JL, ClaudeJR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle aged population. Diabetologia 1980;19:205-210.
6. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2:154-160.
7. Després JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-957.
8. Seltzer HS, Allen EW, Herron AL, Brennan MT. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 1967;46:323-335.
9. Matsui H, Hashimoto H, Fukushima A, Kanayama H, Mitani S, Toki Y, Okumura K, Ito T. MB fraction of cumulative creatine kinase correlates with insulin secretion in patients with acute myocardial infarction. Am Heart J 1996; 131:24-31.
10. Macdonald RG, Henderson MA, Hirshfeld JW Jr, Goldberg SH, Bass T, Vetrovec G, Cowley M, Tassig A, Whitworth H, Margolis JR, Hill JA, Jugo R, Pepine CJ, for the M-HEART Group. Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty - a report from the M-HEART Group. Am J Cardiol 1990;66:926-931.
11. Violaris AG, Melkert R, Serruys PW. Influence of serum cholesterol and cholesterol subfractions on restenosis after successful coronary angioplasty. Circulation 1994;90:2267-2279.
12. Stout RW. Insulin and atheroma: 20-year perspective. Diabetes Care 1990; 13:631-654
13. Hamsten A, Efendic S, Walldius G, Szamosi A, de Faire U. Glucose tolerance and insulin response to glucose in nondiabetic young male survivors of myocardial infarction. Am Heart J 1987;113:917-927.